Fulton Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,228
| Closed | -$335K | – | 675 |
|
|
2025
Q1 | $335K | Sell |
2,228
-1,400
| -39% | -$211K | 0.01% | 502 |
|
|
2024
Q4 | $670K | Buy |
3,628
+232
| +7% | +$42.8K | 0.03% | 356 |
|
|
2024
Q3 | $669K | Buy |
3,396
+91
| +3% | +$17.9K | 0.03% | 351 |
|
|
2024
Q2 | $683K | Buy |
3,305
+157
| +5% | +$32.4K | 0.03% | 327 |
|
|
2024
Q1 | $853K | Buy |
3,148
+40
| +1% | +$10.8K | 0.04% | 300 |
|
|
2023
Q4 | $735K | Buy |
3,108
+193
| +7% | +$45.6K | 0.03% | 302 |
|
|
2023
Q3 | $571K | Buy |
2,915
+333
| +13% | +$65.3K | 0.03% | 331 |
|
|
2023
Q2 | $543K | Buy |
2,582
+127
| +5% | +$26.7K | 0.03% | 330 |
|
|
2023
Q1 | $495K | Buy |
2,455
+387
| +19% | +$78.1K | 0.03% | 328 |
|
|
2022
Q4 | $450K | Sell |
2,068
-470
| -19% | -$102K | 0.03% | 331 |
|
|
2022
Q3 | $500K | Buy |
2,538
+247
| +11% | +$48.7K | 0.03% | 295 |
|
|
2022
Q2 | $490K | Buy |
2,291
+341
| +17% | +$72.9K | 0.03% | 304 |
|
|
2022
Q1 | $554K | Buy |
1,950
+197
| +11% | +$56K | 0.03% | 302 |
|
|
2021
Q4 | $660K | Buy |
1,753
+285
| +19% | +$107K | 0.03% | 292 |
|
|
2021
Q3 | $606K | Buy |
1,468
+110
| +8% | +$45.4K | 0.03% | 293 |
|
|
2021
Q2 | $502K | Sell |
1,358
-9
| -0.7% | -$3.33K | 0.02% | 306 |
|
|
2021
Q1 | $396K | Buy |
1,367
+353
| +35% | +$102K | 0.02% | 327 |
|
|
2020
Q4 | $253K | Buy |
+1,014
| New | +$253K | 0.01% | 389 |
|